Many of the peptides being marketed for injury recovery are: Not FDAapproved Compounded without standardized dosing oversight Purchased online Not subject to the same manufacturing controls as approved medications Competitive athletes should also know that many growthhormonerelated compounds are WADAprohibited
Phukan BC, Roy R, Paul R, Mazumder MK, Nath J, Bhattacharya P, Borah A
B.et al (2008)
10.1016/j.jconrel.2016.08.035 23 XuC.SunL.RenF.HuangP.TianZ.CuiJ.et al (2020)
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
A.JokelainenK.LauG